ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Operating margin (%)

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 202518.2+11.66%
Dec 31, 202416.3+0.73%
Dec 31, 202316.2-15.69%
Dec 31, 202219.2-2.06%
Dec 31, 202119.6+26.36%
Dec 31, 202015.5+8.97%
Dec 31, 201914.2+19.00%
Dec 31, 201811.9+89.42%
Dec 31, 20176.3-58.74%
Dec 31, 201615.3+8.71%
Dec 31, 201514.1+16.76%
Dec 31, 201312-18.72%
Dec 31, 201114.8-14.47%
Dec 31, 201017.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat